IACP News Roundup - October 13, 2017

To keep you informed on all of IACP  member-driven initiatives  and latest legislative & regulatory updates, IACP has debuted a weekly  News Roundup ! Check out this week's report below, and email us at  [email protected]   with questions.



ABOUT

EVP Tracker
  • IACP wants you to have access to the EVP, the staff, as well as the Board of Directors. Stay up-to-date on where IACP's Executive Vice President Cynthia Blankenship, Esq. is traveling, and set-up meetings or come by and say hi! Keep up-to-date on Cynthia's whereabouts with the EVP Tracker and let her know if you would like to host a townhall or meeting at your pharmacy! 
Next on Cynthia's travel plans:    

  • NCPA Annual Convention, Orlando, Fla., Oct. 14-18, 2017 - Come to Booth 1421 and join IACP! Save 20% on NEW memberships! Use Code: NCPA20!
* IACP EVP Cynthia Blankenship has been appointed as the United States Pharmacopeia (USP) delegate representing IACP. The delegate is invited to attend the USP five-year meeting in 2020 and the twice per year Compounding Expert Committee (CEC) meeting as an observer. 

Member Initiatives
  • IACP Initiatives - A Progress Report Card! Keep tuning in to IACP's Executive Vice President (EVP) Cynthia Blankenship's  Member Initiatives to see where we're making progress and what we're checking off the list! You asked IACP for several key changes - and we're making them! IACP is in the midst of reviewing & revitalizing ALL of our current programs. We want to ensure we're completely in tune with our membership, providing you with what you need. Do you have suggestions or questions? Please email [email protected]. 
IACP Call for Board of Directors Nominations
  • Call for IACP Board of Directors Nominations! IACP's Call for Nominations and the Election Cycle for the Board of Directors are now open! IACP needs YOU! YOU are instrumental to the success of IACP and to compounding. Please consider joining the IACP Board of Directors, today! The Bylaws of IACP set forth an open election process with nominations for candidates accepted directly from the membership. This year, there are seven Board of Directors' seats including the position of IACP Vice President available. Obtain more detailed information, including candidate eligibility and term length for each board position, and a Nomination Form! 

Hurricane Maria caused significant and long-term damage to Puerto Rico and the U.S. Virgin Islands. The majority of the region is still without power and now there are serious drug shortage concerns.

IACP Board Member Marisol Lopez, RPh, MPh, University of Puerto Rico School of Pharmacy in Trujillo Alto, Puerto Rico, provides an update.

Please check out the IACP resources packet as well as Marisol's recommendations on how to help!


NEWSROOM

Member Alerts
  • USP announced the intent to postpone the official date of General Chapter <800> Hazardous Drugs - Handling in Healthcare Settings. To protect patients and healthcare workers from potential harm, USP General Chapters <800>  Hazardous Drugs - Handling in Healthcare Settings and <797>  Pharmaceutical Compounding - Sterile Preparations are designed to provide comprehensive standards for all healthcare workers to help ensure the safe handling of hazardous drugs throughout the healthcare system, including in the practice of compounding. The intent of the USP Compounding Expert Committee is that these chapters be implemented at the same time. To honor this intention, the official date of USP General Chapter <800> will be postponed to align with the expected official date of USP General Chapter <797>. The next revision to General Chapter <797> is anticipated to be published in the Pharmacopeial Forum 44(5) September/October 2018 for a second round of public comment. Both USP General Chapter <797> and USP General Chapter <800> are anticipated to become official on December 1, 2019 .
Member Newsletter
Media

 
News Story Features IACP Member Saad Dinno, RPh, FIACP!


Happy 20th!!    IACP Member Saad Dinno, RPh, FIACP and staff at  Acton Pharmacy in Acton, Massachusetts are celebrating their pharmacy's 20th anniversary! 

View Wicked Local - Acton news story here !

Thank you for being an IACP member and for making a real difference in your patients' lives with compounded medications!

#CompoundingHero!

  • STAT - Scott Gottlieb Rocketed to the Top of FDA. He May Keep Rising - October 4, 2017
  • Pharmacy Times: Patients Want to Interact with Their Pharmacists on Social Media - October 4, 2017
     
MEMBERSHIP

Membership Survey
  • IACP's Membership Survey is Out! IACP is seeking your input on our programs, services, products, and demographics about your practice. IACP values our members and your feedback! We will use YOUR feedback to shape not only the direction of IACP, but also the resources IACP provides, our communications to you, and our events!  IACP Members: Click here to complete the survey. IACP will be keeping in touch with you and regularly engaging your opinions. And, most importantly, communicating back to you the changes we're making based on your opinions.
Membership Drive
  • IACP Extends Membership Drive! Sign Up your Staff for 25% off NEW IACP Memberships. Share this with Your Colleagues! Due to the incredible number of members to join IACP during the membership drive and the interest expressed, IACP has extended our membership drive! Use code CCH25, and click here to save! 
ADVOCACY

Federal Advocacy
  • Your Efforts are Making a Difference! We Now Have 40 HR 2871 Cosponsors! Has Your Representative Signed On? Please send a direct communication to your Member of Congress. HR 2871 will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and most importantly, better balance public safety and patient access. Act, Today!
State Advocacy
  • NOW AVAILABLE FROM IACP! State-by-State Analysis of Office-Use Compounding Regulations! Your Government Affairs team just released a State-by-State Analysis of Office-Use Regulations! We researched State regulations, State notices, State activity, and called State Boards of Pharmacy when regulations conflicted with actions to determine each State's office-use actions. In the instance where a State had recently changed its office-use practices, we called to determine why, and the response was noted when FDA had communicated that State law was pre-empted with Federal law.
You will find two documents - (1) the State-by-State analysis and (2) a complete supplemental document where all State regulations and actions are housed. The State-by-State analysis is a quick reference guide that demonstrates State regulations and current thinking on office-use and all supporting documents to this research can be found in the supplemental document. The DQSA Coalition intends to use this document to see whether model office-use State laws exist, to educate and assist States that are attempting to change office-use practices on the intent of Congress, and to focus on specific states for the State Board of Pharmacy/Board of Medicine Coalition Letter that is coming soon! 
  • IACP provides our members with a weekly state tracking report - including legislative and regulatory updates! Check out this week's Compounders Stateside report here - you will need to log-in to view this members-only report.  
  • Florida - IACP Submits Comments to Florida State Board of Pharmacy. 
  • USP General Chapter <800> State Adoption Status Chart. NASPA has developed a chart providing each state's current adoption status of USP's General Chapter <800>. Thank you, IACP Affiliate NASPA, for developing this invaluable tool!
Grassroots
  • Grassroots Advocacy - Tell Your Patients and Providers to sign up for the Partnership for Personalized Prescriptions P3 Patient Advocacy Website! Patient Advocacy efforts make a real difference. That's why we need our IACP members' help to encourage more people to Join P3 and to Share their Stories! So many of our own IACP members have joined the P3 effort. Share this resource with everyone in your communities - your patients, your providers, your staff, your friends and family.
  • Your Patients and Providers are Asking their Representatives to Support HR 2871 with more than 518 messages sent to the Hill! Encourage your patients and providers to visit P3's Patient Advocacy Website. Advocates can instantly send a direct message to their Congressional Representatives, asking them to cosponsor the bipartisan legislation, HR 2871. Visit P3's Patient Advocacy Website. It's easy to use and will only take a few minutes to send an important HR 2871 message to Congress.
  • IACP MEMBERS: We NEED your patient stories to feature on the P3 website - how have compounded medications helped your community? Please email Dagmar Anderson Climo, VP of IACP Communications at [email protected].